Literature DB >> 7058822

Antidiuretic hormone in congestive heart failure.

G A Riegger, G Liebau, K Kochsiek.   

Abstract

In advanced heart failure, severe edema develops associated with hyponatremia. In 20 patients with severe congestive heart failure, we studied plasma antidiuretic hormone (ADH) concentrations related to hemodynamics and plasma osmolality. Prazosin was used to test the acute response to changes in atrial receptors and hemofiltration to test the response to changes in volume receptors. One group of the patients had inappropriately high ADH values (14.5 +/- 8.8 pg/ml) in relation to their plasma osmolality, which was well below normal values (276 +/- 23 mosmol/kg water) with no apparent osmoregulatory control. The other group showed a normal relationship of ADH and plasma osmolality (3.9 +/- 1.0 pg/ml; 289 +/- 8 mosmol/kg water), Only in the normal regulating group did lowering of left atrium pressure by prazosin result in a rise in ADH related to the decrease in pressure. Inappropriately high ADH secretion could be reversed by hemofiltration. This suggests that the syndrome of "dilutional hypo-osmolality" in severe congestive heart failure may be caused by an inappropriately high ADH secretion in which the osmoreceptor system is dominated by nonosmolar stimuli; however, it cannot be ruled out that associated hemodynamic effects in the kidney or other intrarenal or hormonal factors contribute to this mechanism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7058822     DOI: 10.1016/0002-9343(82)90576-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  22 in total

Review 1.  Neurocardiology: therapeutic implications for cardiovascular disease.

Authors:  David S Goldstein
Journal:  Cardiovasc Ther       Date:  2010-11-25       Impact factor: 3.023

Review 2.  Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

3.  STEMI complicated with serum sodium of 113 mmol/L from syndrome of inappropriate antidiuretic hormone secretion: How worse could it be?

Authors:  Pongsathorn Kue-A-Pai; Saranya Buppajarntham
Journal:  J Cardiol Cases       Date:  2014-08-14

4.  Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor.

Authors:  J Fukuzawa; T Haneda; K Kikuchi
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

Review 5.  Hyponatraemia: more than just a marker of disease severity?

Authors:  Robert W Schrier; Shailendra Sharma; Dmitry Shchekochikhin
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

6.  Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit.

Authors:  L Arnolda; B P McGrath; M Cocks; C I Johnston
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

7.  The cardiorenal syndrome: making the connection.

Authors:  Gautham Viswanathan; Scott Gilbert
Journal:  Int J Nephrol       Date:  2010-10-04

8.  Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department.

Authors:  Luigi Mario Castello; Marco Baldrighi; Alice Panizza; Ettore Bartoli; Gian Carlo Avanzi
Journal:  Intern Emerg Med       Date:  2016-07-21       Impact factor: 3.397

9.  Role of volume in the regulation of vasopressin secretion during pregnancy in the rat.

Authors:  W M Barron; B A Stamoutsos; M D Lindheimer
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

Review 10.  Peripheral factors in the management of congestive heart failure.

Authors:  L Demopoulos; T H LeJemtel
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.